The Journal of Cancer and Medical Imaging (JCMI) is a platform dedicated to sharing current insights in cancer research and medical imaging, focusing on discovery and facilitating communication among researchers and physicians.
JCMI strives to be a primary journal that publishes original case studies, research articles, clinical reviews, brief reports, case reports, clinical trial design, case record form design, data collection, quality assurance, etc., covering all oncology areas. JCIM encompasses all aspects of pathophysiology, diagnosis, prevention, and treatment of cancer, including the finding of rare diseases.
JCMI is a bimonthly, peer-reviewed, open-access online journal that provides a public platform for researchers, healthcare professionals, and scientists worldwide to communicate, share, and discuss cancer research and treatment advancements.
Objective:
The journal's primary focus is to provide a scientific communication medium for discussing the latest advancements in the cancer domain.
Aim:
This journal aims to centralize and back up meticulous data on this vital subject for future research.
Scope
This journal covers cancer research, including oncology, carcinogenesis, research, epidemiology, cytopathology, metastasis, leukemia, bone cancer, therapeutics, DNA repair, and more.
Time frame:
JCMI publishes articles after a double-blind peer-review process. Once published, the articles can be immediately accessed and reused with proper credit for non-commercial purposes.
This journal is affiliated with the principles set by the Committee on Publication Ethics (COPE)
Open Access Publication and Creative Commons Licensing:
The publication is open-access and distributed under the terms of Attribution 4.0 International (CC By 4.0)
Share - You can copy and reshare the material in any format or medium
Adapt - Transform, remix, and build upon the material for any purpose, even commercial use.
Under the following terms:
This journal operates on an open-access basis, allowing articles to be shared and redistributed in any format under the terms of the Attribution 4.0 International (CC BY 4.0) license. This means the material can be adapted and built upon for various purposes, including commercial use.
Attribution - Proper credit is mandatory, along with a link to the license. Also, mention if you have made any modifications. However, refrain from implying that the licensor endorses you or your use.
No additional restrictions: You may not impose technological or legal measures that restrict others from exercising the rights that licence permits.
Ahead of Print policy:
Online first articles are considered published and can be cited using DOI. Aspirant Publications does not allow modifications after publication. Contact the editorial office for any necessary changes through email at xxxxxxxxxx
Scope of the journal but not narrowed to: